Hunan Jingfeng Pharmaceutical Co (SZSE:000908) YoY EBITDA Growth : -41.67% (As of Mar. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Hunan Jingfeng Pharmaceutical Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Hunan Jingfeng Pharmaceutical Co's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was -41.67%.

Hunan Jingfeng Pharmaceutical Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.01.

Hunan Jingfeng Pharmaceutical Co YoY EBITDA Growth Historical Data

The historical data trend for Hunan Jingfeng Pharmaceutical Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hunan Jingfeng Pharmaceutical Co YoY EBITDA Growth Chart

Hunan Jingfeng Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

-288.67

-14.61

105.76

-55.36

-504.00

Hunan Jingfeng Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial															-29.41	-28.57	-214.29	-90.32	-41.67

Hunan Jingfeng Pharmaceutical Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Hunan Jingfeng Pharmaceutical Co's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(-0.101	-	0.025)	/	\| 0.025 \|
=	-504.00 %

Hunan Jingfeng Pharmaceutical Co's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(0.014	-	0.024)	/	\| 0.024 \|
=	-41.67 %

Hunan Jingfeng Pharmaceutical Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Hunan Jingfeng Pharmaceutical Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Hunan Jingfeng Pharmaceutical Co (SZSE:000908) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Jingfeng Pharmaceutical Co Ltd (SZSE:000908) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

500 Zhangyang Road, Pudong New District, 30th Floor, China Resources Times Square, Shanghai, CHN

Website

http://www.jfyiyao.com

Hunan Jingfeng Pharmaceutical Co Ltd is engaged in the manufacturing of pharmaceutical products in China. The company offers Chemical medicine, Biological medicine, and Traditional Chinese medicine. Some of its products include Lemai Wan, Analgesic, Fuping Capsules, and Tongdi Capsules among others.

Executives

Zhou Shen Dong	Supervisors
Ye Xiang Wu	Directors, executives
Ma Xian Peng	Executives
Cong Shu Fen	Executives
Zhang Jun Guo	Executives
Jian Wei Guang	Directors, executives
Bi Yuan	Secretary, Director
Ou Yang Yan Li	Secretary, Director
Luo Li	Director
Luo Bin	Director
Li Tong	Directors, executives
Wei Ze Chun	Director
Tang Zhi	Executives
Ou Yang Chun Bao	Executives
Mao Hui	Executives

Hunan Jingfeng Pharmaceutical Co (SZSE:000908) Headlines

No Headlines